ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 0996

Will Patients Engage with Digital Technologies as Part of Routine Healthcare?

Jeffrey R Curtis1, Sandeep Sodhi2, Yuji Su3, Scott Laster4, Fenglong Xie2, Ye Liu5 and Corey Patrick4, 1Division of Clinical Immunology and Rheumatology, University of Alabama, Birmingham, AL, 2Illumination Health, Hoover, AL, 3University of Alabama at Birmingham and Illumination Health, Birmingham, AL, 4Micare, Memphis, TN, 5University of Alabama at Birmingham, Birmingham, AL

Meeting: ACR Convergence 2023

Keywords: autoimmune diseases, Health Services Research, quality of care, rheumatoid arthritis

  • Tweet
  • Email
  • Print
Session Information

Date: Monday, November 13, 2023

Title: (0993–1012) Health Services Research Poster II

Session Type: Poster Session B

Session Time: 9:00AM-11:00AM

Background/Purpose: Remote Physiologic Monitoring (RPM) and Remote Therapeutic Monitoring (RTM) are new care delivery options by which patients can provide data to their provider via a biosensor device and/or smartphone app in an insurance reimbursable fashion. However, patients’ willingness and persistence to engage in RPM/RTM over time is unclear.

Methods: Using data from 9/2020 – 5/2023, we examined characteristics of patients who enrolled in a national RPM/RTM program as part of routine care, stratified by medical specialty. Time on the program began at the time patients were first enrolled in the program and contributed data and continued until they voluntarily withdrew from the program, were lost to follow up (i.e. became inactive) or were censored. Kaplan Meier curves described persistence over time, stratified by medical specialty, combining musculoskeletal (orthopedics and rheumatology) and Others (e.g. pulmonology, primary care) into a single group. Cox proportional hazards models evaluated the time to discontinuation by medical specialty, adjusting for age and sex.

Results: A total of 1797 patients were enrolled, with characteristics as described in table 1.Mean age was greater than 70 years for all cohorts except endocrinology. Persistence with RPM/RTM significantly differed by specialty (Figure). Approximately 80% of patients being monitored for musculoskeletal conditions were approximately 80% adherent at 6 months. Referent to patients being monitored for musculoskeletal conditions (e.g. rheumatology), persistence with RPM/RTM was worse for patients being monitored for endocrinology conditions (age-sex-adjusted hazard ratio for non-persistence=2.3, 95% CI 1.8-2.8) and was not different for other specialties.

Conclusion: Most patients with musculoskeletal or other chronic health conditions are persistent with digital health care delivery systems such as remote physiologic and remote therapeutic monitoring. Strategies to optimize patient engagement with such programs are important to maximize the health benefits of these new digital healthcare delivery mechanisms.

Supporting image 1


Disclosures: J. Curtis: AbbVie, 2, 5, Amgen, 2, 5, BMS, 2, 5, Corrona, 2, 5, Crescendo, 2, 5, Genentech, 2, 5, Janssen, 2, 5, Pfizer, 2, 5, Roche, 2, 5, UCB Pharma, 2, 5; S. Sodhi: None; Y. Su: None; S. Laster: None; F. Xie: None; Y. Liu: None; C. Patrick: None.

To cite this abstract in AMA style:

Curtis J, Sodhi S, Su Y, Laster S, Xie F, Liu Y, Patrick C. Will Patients Engage with Digital Technologies as Part of Routine Healthcare? [abstract]. Arthritis Rheumatol. 2023; 75 (suppl 9). https://acrabstracts.org/abstract/will-patients-engage-with-digital-technologies-as-part-of-routine-healthcare/. Accessed .
  • Tweet
  • Email
  • Print

« Back to ACR Convergence 2023

ACR Meeting Abstracts - https://acrabstracts.org/abstract/will-patients-engage-with-digital-technologies-as-part-of-routine-healthcare/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology